Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Florida State University Research Foundation Incorporated currently manages a specialized portfolio in the Biotechnology & Pharmaceuticals technology area. The data shows 1 pending office action, which represents the entirety of the foundation's active prosecution in this space. This case is assigned to 1 distinct examiner, BUNNER, BRIDGET E. Consequently, BUNNER, BRIDGET E is the busiest examiner for the portfolio with 1 pending case. This concentration of work suggests that the foundation's immediate patent acquisition efforts in Biotechnology & Pharmaceuticals are focused on a single matter.
The foundation's work is concentrated within 1 distinct art unit, reflecting a specific technical focus. This lack of distribution across different units suggests a highly targeted research and filing strategy. For a practitioner, the presence of 1 pending office action means that resources can be fully committed to resolving the specific hurdles of this application. Because the portfolio involves 1 distinct examiner, there is a unique opportunity to build a consistent rapport with BUNNER, BRIDGET E. The focus on 1 distinct art unit ensures that the prosecution remains within a single specialized technical community, providing a stable environment for intellectual property development.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BUNNER, BRIDGET E | 1 | 64.5% | +19.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18047741 | CD24-LOADED VESICLES FOR TREATMENT OF CYTOKINE STORM AND OTHER CONDITIONS | BUNNER, BRIDGET E | 126d overdue |
| Art Unit | Apps |
|---|---|
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18047741 | CD24-LOADED VESICLES FOR TREATMENT OF CYTOKINE STORM AND OTHER CONDITIONS | BUNNER, BRIDGET E | 1647 | §103§112DP | Final Rejection | 126d overdue | Pending | Oct 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial